Changing attitudes and regulations concerning marijuana in recent years have pushed the drug (and its derivatives) onto the national main stage. Discussions concerning the use of marijuana and the potential uses for marijuana have made their way into dozens of industries – to which the dietary supplement industry is no exception.
Which is why it probably doesn’t come as much of a surprise to you (or anyone, for that matter) that the number of requests and inquiries for dietary supplements containing CBD (Cannabidiol) oil have skyrocketed in recent years.
When it comes to CBD oil and supplements, what the most popular question that we receive?
Can you help us manufacture a dietary supplement formula that contains CBD oil?
The short answer? Nope. The fact of the matter is, as of the time when this article was published, there are no manufacturers out there who would be capable of helping any supplement brand owner manufacturer a dietary supplement product containing CBD oil or any cannabidiol substances.
Here are some of the primary reasons why this happens to be the case.
FDA: “cannabidiol products are excluded from the dietary supplement definition”
Plain and simple, for better or for worse, the FDA’s current stance on cannabidiol products is that they do not meet the current standards for dietary supplements or dietary ingredients.
For those with the time, patience, and desire to read through the section of federal legislation that the FDA believes cannabidiol products are not in compliance with can do so by pulling up section 201(ff)(3)(B)(ii) of the FD&C (Federal Food, Drug, and Cosmetic) Act.
While there are certain exceptions to the rule outlined in the referenced section of the FD&C Act, the FDA has also concluded that cannabidiol products (currently) do not qualify for any of these exemptions.
Bottom Line: Until the FDA’s official stance on cannabidiol products changes, no one in the nutraceutical industry will be able to legally manufacture, market, or sell dietary supplement products containing CBD oil or other marijuana derivatives.
The FDA’s stance on marijuana and CBD products probably isn’t going to change anytime soon.
From what we’ve observed, this may be a perfect “actions speak louder than words” scenario.
Along with no recent changes to their stance on marijuana-derived products and substances, the FDA has consistently gone so far as to send warning letters to companies with supplement products that violate the current regulations.
Since last year the FDA has delivered more than a dozen cannabidiol related warning letters.
The Future of CBD products and Supplements
Even if nothing is written in stone, it looks like brand owners and entrepreneurs who are seeking CBD-based opportunities within the world of dietary supplements are going to have to be patient.